ID   SK-RC-20
AC   CVCL_V605
SY   SK RC 20; SKRC-20; SKRC20
DR   BioSample; SAMN10988408
DR   CCLE; SKRC20_KIDNEY
DR   DepMap; ACH-000385
DR   PharmacoDB; SKRC20_1414_2019
DR   Wikidata; Q54954559
RX   PubMed=25984343;
RX   PubMed=31068700;
CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 55 hours (PubMed=25984343).
CC   Omics: Deep exome analysis.
CC   Omics: shRNA library screening.
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D16S539: 11,12
ST   D19S433: 14,15
ST   D21S11: 32.2
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 12,15
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C9385; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 12-01-21; Version: 10
//
RX   PubMed=25984343; DOI=10.1038/sdata.2014.35;
RA   Cowley G.S., Weir B.A., Vazquez F., Tamayo P., Scott J.A., Rusin S.,
RA   East-Seletsky A., Ali L.D., Gerath W.F.J., Pantel S.E., Lizotte P.H.,
RA   Jiang G.-Z., Hsiao J., Tsherniak A., Dwinell E., Aoyama S., Okamoto M.,
RA   Harrington W., Gelfand E., Green T.M., Tomko M.J., Gopal S.,
RA   Wong T.C., Li H.-B., Howell S., Stransky N., Liefeld T., Jang D.,
RA   Bistline J., Meyers B.H., Armstrong S.A., Anderson K.C.,
RA   Stegmaier K., Reich M., Pellman D., Boehm J.S., Mesirov J.P.,
RA   Golub T.R., Root D.E., Hahn W.C.;
RT   "Parallel genome-scale loss of function screens in 216 cancer cell
RT   lines for the identification of context-specific genetic
RT   dependencies.";
RL   Sci. Data 1:140035-140035(2014).
//
RX   PubMed=31068700; DOI=10.1038/s41586-019-1186-3;
RA   Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C.,
RA   McDonald E.R. III, Barretina J., Gelfand E.T., Bielski C.M., Li H.,
RA   Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F.,
RA   Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R.,
RA   Lu Y., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C.,
RA   Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A.,
RA   Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D.,
RA   Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L.,
RA   Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A.,
RA   Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D.,
RA   Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M.,
RA   Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R.,
RA   Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A.,
RA   Sellers W.R.;
RT   "Next-generation characterization of the Cancer Cell Line
RT   Encyclopedia.";
RL   Nature 569:503-508(2019).
//